Full-Time

Nonclinical Regulatory Writing

Multiple Teams

Posted on 7/23/2026

MMS

MMS

1,001-5,000 employees

Regulatory compliance and data solutions provider

No salary listed

Plymouth, MI, USA

Remote

Category
Biology & Biotech (1)
Required Skills
Sharepoint
Pharmacology
Google Cloud Platform

Get referred to MMS

Find people who can refer or advise you

Requirements
  • BS in pharmacology, toxicology, biology or chemistry, or related field, with industry experience within regulatory writing, regulatory affairs, laboratory sciences, quality assurance/control
  • Knowledge of GLP, ICH guidelines, and applicable regulatory requirements
  • 2+ years of pharmaceutical regulatory nonclinical writing experience
  • Strong writing and analytical skills
  • Proficiency with MS Office applications.
  • Hands-on experience with clinical trial and pharmaceutical development preferred
  • Basic understanding of CROs and scientific & nonclinical data/terminology, & the drug development process
Responsibilities
  • Strong experience with development and writing of nonclinical documents (eg, Module 2.4 and 2.6 eCTD submission documents, Investigator’s Brochure [IB], Nonclinical Study Reports, Meeting Requests, Briefing Documents, RTQs)
  • Lead projects independently with minimal oversight, lead the writing (structure, content and messaging) of nonclinical documents, ensure the nonclinical package aligns with current regulatory guidelines and meets scientific integrity
  • Ability to author based on highly technical sources such as GLP and non-GLP nonclinical study reports, in vivo and in vitro nonclinical data
  • Ability to develop a mapping plan for the placement of nonclinical studies within structure of Module 2.4 and 2.6 eCTD submission documents
  • Interpret and analyze applicable pharmacokinetics, pharmacology, and toxicology data (eg, Prism files, bioanalytical reports, clinical pathology reports, PK/TK evaluation reports)
  • Collaborate with cross-functional teams such as project management, safety, efficacy, biostats, regulatory operations, and CMC
  • Demonstrated ability to lead others to complete complex projects
  • Ability to complete documents according to sponsor’s format, processes, and according to regulatory guidelines
  • Ability to effectively operate in an environment that requires negotiation, persuasion, collaboration, and analytical judgment
  • Organizational expert within the nonclinical subject area
  • Excellent written/oral communication and strong time and project management skills
  • Ability to attend regular team meetings, lead client meeting and CRMs
  • Ability to work in various client systems (eg, SharePoint, Veeva RIM, PleaseReview, EndNote), templates and toolbars
  • Strong understanding of regulatory guidances as it applies to nonclinical submission documents and drug development (eg, ICH, FDA and EMA regulations and guidelines, GLP, GCP, GMP and GDP)

MMS Holdings is a global contract research organization (CRO) focused on regulatory compliance and data-driven solutions for pharmaceutical and biotech sponsors. It delivers services such as regulatory submissions, clinical trial management, data analytics, and medical writing through a service-based model that relies on established processes and experienced advisors. Its work is contract-based, often long-term, aimed at helping clients meet regulatory requirements, run trials efficiently, and advance therapies under FDA guidance. The company differentiates itself with a science-first approach, a strong track record (97% client satisfaction), and involvement in complex areas like enabling MDMA-assisted therapy research, underscoring a commitment to high-quality, compliant outcomes for sponsors globally.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Canton, Ohio

Founded

2006

Get referred to MMS

Find people who can refer or advise you

Growth & Insights and Company News

Headcount

6 month growth

20%

1 year growth

20%

2 year growth

20%
MMS Holdings
Feb 12th, 2025
MMS Acquires Exploristics for Data Science Expansion

MMS, a clinical research organization, has acquired Exploristics, a biostatistics and data science company. This acquisition enhances MMS' capabilities in advanced clinical trial design and data science, integrating Exploristics' KerusCloud® platform. The move expands MMS' global presence, particularly in Europe, and aims to optimize drug development strategies, reducing time and costs. Exploristics' CEO, Aiden Flynn, joins MMS as Senior VP, Head of Strategic Statistical Consulting.

MMS Holdings
Apr 18th, 2023
MMS Named Great Place To Work In The UK

MMS Holdings Inc. plan to expand and grow in the UK and Europe to build on its teams and deliver value to its clients”

Applied Clinical Trials
Apr 14th, 2023
People and Business News – 4/23

EmVenio Research announced the appointment of Mark Mackenzie, MD, as chief medical officer.